Tidal Investments’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,750
Closed -$14K 1953
2024
Q4
$14K Buy
+1,750
New +$83.6K ﹤0.01% 1820

Other funds holding MRNA

Tidal Investments's MRNA Position: Q1 2026 in Review

Tidal Investments increased its Moderna (MRNA) stake by 501% in Q1 2026, buying an estimated $3.77M and bringing the position to 97,031 shares worth $4.76M. The position accounts for 0.01% of the portfolio, ranked #822.

Tidal Investments first reported a position in MRNA in Q4 2020 and has held it in 22 quarters since. The position peaked at $7.68M in Q4 2024. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Tidal Investments held 97,031 shares of Moderna worth $4.76M as of Q1 2026.
  • Tidal Investments bought 80,895 Moderna shares in Q1 2026, an estimated $3.77M.
  • Moderna made up 0.01% of Tidal Investments's portfolio in Q1 2026, its #822 holding.
  • Tidal Investments first reported a position in Moderna in Q4 2020 and has held it in 22 quarters since.
  • Tidal Investments's Moderna position peaked at $7.68M in Q4 2024.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Tidal Investments's 13F filing for Q1 2026, filed 15 May 2026.